Engineers Gate Manager’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164K Buy
+20,900
New +$147K ﹤0.01% 2003
2026
Q1
Sell
-10,354
Closed -$43.1K 2267
2025
Q4
$43.1K Buy
+10,354
New +$58.8K ﹤0.01% 1989
2024
Q1
Sell
-1,023
Closed -$11.2K 2005
2023
Q4
$11.2K Hold
1,023
﹤0.01% 1922
2023
Q3
$10.5K Hold
1,023
﹤0.01% 1727
2023
Q2
$16.1K Buy
1,023
+201
+24% +$4.6K ﹤0.01% 1668
2023
Q1
$18.6K Sell
822
-191
-19% -$6.29K ﹤0.01% 1593
2022
Q4
$36.2K Buy
1,013
+50
+5% +$1.98K ﹤0.01% 1571
2022
Q3
$38K Sell
963
-358
-27% -$17K ﹤0.01% 1517
2022
Q2
$63K Buy
+1,321
New +$77.5K ﹤0.01% 1779

Other funds holding DTIL

Engineers Gate Manager's DTIL Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Precision BioSciences (DTIL) in Q2 2026: 20,900 shares worth $164K. The stake represents ﹤0.01% of the portfolio and ranks #2003 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in DTIL as recently as Q4 2025.

Engineers Gate Manager first reported a position in DTIL in Q2 2022 and has held it in 9 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Engineers Gate Manager held 20,900 shares of Precision BioSciences worth $164K as of Q2 2026.
  • Precision BioSciences was a new Engineers Gate Manager position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2003 holding.
  • Engineers Gate Manager first reported a position in Precision BioSciences in Q2 2022 and has held it in 9 quarters since.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.